Lumos Pharma, Inc. Common Stock

Go to Lumos Pharma, Inc. Common Stock Website

$4.34

(%)
Live
Previous Close

$4.34

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$

Day Vol.

Previous Day Vol.

Currency

Primary Exchange

Nasdaq

...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Monteverde & Associates PC is investigating the proposed merger between Lumos Pharma Inc. (NYSE: LUMO) and Double Point Ventures LLC, where Double Point Ventures will acquire Lumos Pharma's outstanding shares for $4.25 per share in cash, plus one non-transferable unsecured Contingent Value Right per share.

Related tickers: LUMO.

Read Full Article

Lumos Pharma, a clinical-stage biopharmaceutical company, announced its participation in the H.C. Wainwright 26th Annual Global Investment Conference, where it will host one-on-one meetings and present its corporate overview.

Related tickers: LUMO.

Read Full Article
Trending Tickers

Please sign in to view